365Telugu.com online news,Hyderabad, April 4, 2025: Startoon Labs Private Limited, a Hyderabad-based MedTech company specializing in R&D and manufacturing of innovative joint and muscle health devices, has announced a significant partnership with Medplus, one of India’s leading pharmacy retail chains. The collaboration will see the deployment of Pheezee, Startoon Labs’ pioneering diagnostic device, across Medplus diagnostic centres to initiate comprehensive muscle and joint health assessments.
Medplus Diagnostics, which provides pathology and radiology services under the umbrella of Medplus Health Services, will now expand its offerings by integrating Pheezee-based diagnostics into its centers. This marks a crucial step towards accessible and accurate musculoskeletal health monitoring for Indian patients.
ఇది కూడా చదవండి..మారికో ఇన్నోవేషన్ ఫౌండేషన్ ‘ఇన్నోవిన్ డే’కు శ్రీకారం..
Read this also…Marico Innovation Foundation Launches InnoWin Day to Accelerate India’s Cleantech, Circularity, and Agritech Innovations..
Developed by Startoon Labs and listed with the USFDA, Pheezee is the world’s first-of-its-kind wearable diagnostic and prognostic device. It enables physiotherapists and healthcare providers to track functional recovery in patients undergoing physiotherapy. The device leverages AI-powered insights, offering personalized reports that identify affected muscles, providing a roadmap for targeted and effective treatment.
Unlike traditional imaging methods like X-rays or MRIs that offer only static images, the non-invasive Pheezee test evaluates real-time muscle function and nerve communication, delivering deeper diagnostic insights that help treat the root cause of pain—not just the symptoms.
A Game Changer for Patients and Professionals
The Pheezee test is especially beneficial for patients suffering from joint pain, musculoskeletal disorders, posture-related issues, and neurological conditions. It is already being utilized by reputed institutions such as Tapadia, Anvayaa, and TGSRTC. Notably, TGSRTC uses Pheezee to evaluate its drivers for pain, improving overall operational efficiency.
Speaking about the collaboration, Dr. Srivani, Physiotherapist, stated:
“Pheezee is a powerful diagnostic tool that assesses muscle function and nerve response—crucial in identifying conditions like joint pain and muscle disorders.”
Suresh Susurla, CEO and Co-founder of Startoon Labs, added:
“A Pheezee test report offers critical physiological data not captured in traditional diagnostic tools. When combined with imaging reports, it enhances the clinical diagnosis process for orthopedists and neurologists.”
Read this also…What is the Real Purpose of the Waqf Board?
ఇది కూడా చదవండి..వక్ఫ్ బోర్డు అసలు లక్ష్యం ఏంటి..?
Ms. Mythreyi Kondapi, CTO and Co-founder of Startoon Labs, emphasized the broader impact of this launch:
“Millions suffer from undiagnosed muscle and nerve conditions due to lack of advanced facilities. Pheezee bridges this gap using technologies like Electromyography and Range of Motion analysis. Early detection of conditions like arthritis, muscle dystrophy, and carpal tunnel syndrome means faster and better recovery.”
India’s Booming MedTech Sector
This partnership arrives at a time when India’s MedTech industry is booming—valued at $15.35 billion in 2023 and projected to reach $20.51 billion by 2029 at a CAGR of 5.35%. Startoon Labs, with innovations like Pheezee, is helping India capture a larger share of the 1.65% global medical device market.
This initiative not only enhances the scope of diagnostics at Medplus, but also paves the way for early-stage intervention and better rehabilitation outcomes for millions across India.